ro glp 1 login SERENA WILLIAMS JOINS AS GLP-1 CELEBRITY AMBASSADOR Introducing the Ro Mobile App

Learn how to partner with us

Kathy J

Many of the neuroprotective, neurodegenerative, psychiatric, and addiction-related applications discussed remain investigational, and no GLP-1 receptor agonist is currently approved by regulatory authorities for the treatment or prevention of Alzheimers disease, Parkinsons disease, depression, substance use disorders, or other neurological indications unless specifically stated otherwise

Again, no actual GLP-1 compounds and no clinical evidence for transdermal delivery of the listed ingredients

& Thompson, A

Reduced appetite: GLP-1 medications can result in a lack of interest in food, potentially leading to undereating, causing nutrient deficiencies and potential muscle loss